In pancreatic cancer, it has been reported that high expression of ITGB1 is involved in the migration of cancer cells [34], and that high expression of ITGB1 and ITGA3 confers resistance to gemcitabine by increasing integrin α3β1 signaling [35]. This evidence concerns the gene ITGA3 and familial pancreatic carcinoma.